Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

36,447 stories, page 128 of 608

Advanced search

🌍Sep 2Researchdoi.org

Vitamin D Supplementation in Infertile Men: Beyond Pooled Effects—A Critical Meta-Analysis of Heterogeneous Clinical Responses

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Clinical application of sugammadex in renal impairment: pharmacokinetics and pharmacodynamics

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Correction: Comparative assessment of the activity of racemic and dextrorotatory forms of thioctic (alpha-lipoic) acid in low back pain: preclinical results and clinical evidences from an open randomized trial

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Repeated voriconazole therapeutic drug monitoring in hospitalised patients: a real-world cohort study of out-of-range exposure and concentration response to dose adjustment

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Editorial: From black-box to clarity in lesion diagnostics: clinical causal cognition led interpretable diagnostic AI systems

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Gut microbiota dysbiosis and the gut–lung axis in COPD: mechanisms, clinical relevance, and microbiota-targeted interventions

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Review of: "Integrity of Clinical RCTs: Safeguarding Trust, Evidence, and Patient Welfare"

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Recognizing strengths in individuals with ADHD: Exploring experiences and applications in clinical practice

CrossrefOriginal source

🌍Sep 2Researchdoi.org

The impact of intraoperative epiaortic scanning of the ascending aorta on the tactics and outcomes of coronary artery bypass grafting (literature review)

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Identifying key prognostic indicators for extended hemodialysis survival: A comprehensive analysis of clinical, laboratory, and demographic factors

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Evaluation of natural and synthetic photosensitizers in visible light-mediated antimicrobial photodynamic therapy against pathogenic bacteria

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Cancer Outcomes in Low- and Middle-income Countries: The Role of Clinical, Sociodemographics, and Public Funding as Drivers

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Prediction of non-surgical spinal decompression efficacy in lumbar disc herniation patients is based on pre-treatment paravertebral muscle MRI radiomics and clinical factors in a two-center study with external validation.

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Optimizing Physiological Image Compression via Discrete Wavelet Transform without Loss of Clinical Relevance

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Clinical and Inflammatory Benefits of Nebulized Furosemide with Salbutamol–ipratropium in COPD Exacerbations: A Randomized Controlled Trial

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Study of the clinical presentation and antibiotic susceptibility pattern of Burkholderia pseudomallei infection from a tertiary care hospital

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Approach to the Patient: Theranostics as precision medicine for neuroendocrine tumors

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Association of admission LDL cholesterol with clinical profile and 3-months outcomes after ischaemic stroke

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Knowledge, TDM-related practices, and training needs regarding the clinical use of vancomycin among healthcare professionals in China: a cross-sectional survey

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Mistreatment, gender differences, and reporting behaviors among medical students in clinical training in Taiwan: a nationwide cross-sectional study

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Clinical rationale and indications for the use of cone-beam computed tomography

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Evaluating a sexual violence primary prevention program at an Australian University: a realist protocol comprising a cluster non-randomized controlled trial and realist interviews

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Automated whole-brain MRI segmentation combined with clinical scores for the diagnosis of sepsis-associated encephalopathy: a case-control study

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Wellbeing, mastery and work participation: Effects of the Five Ways to Wellbeing course—a randomized controlled trial

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Intravascular hemolysis and clinical outcomes in continuous-flow LVAD patients: A single-center retrospective analysis

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Data from Antibody–Drug Conjugates Prepared with Peptide Asparaginyl Ligases Achieve Strong In Vitro and In Vivo Antitumor Activity

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Supplementary Figure S2 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Supplementary Figure S3 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Supplementary Figure S5 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Supplementary Figure S7 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Supplementary Figure 4 from Antibody–Drug Conjugates Prepared with Peptide Asparaginyl Ligases Achieve Strong In Vitro and In Vivo Antitumor Activity

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Supplementary Figure 6 from Antibody–Drug Conjugates Prepared with Peptide Asparaginyl Ligases Achieve Strong In Vitro and In Vivo Antitumor Activity

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Supplementary Figure 7 from Antibody–Drug Conjugates Prepared with Peptide Asparaginyl Ligases Achieve Strong In Vitro and In Vivo Antitumor Activity

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Varying Cancer Drug Doses to Balance Tumor Control and Resistance Evolution

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Supplementary Information from Evolutionary Antifragile Therapy Is a Treatment Strategy to Suppress Drug Resistance by Exploiting Dose–Response Convexity

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Figure 2 from KRAS Inhibitor–Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Figure 5 from KRAS Inhibitor–Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Figure S11 from KRAS Inhibitor–Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Figure S4 from KRAS Inhibitor–Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Figure S5 from KRAS Inhibitor–Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Table S3 from KRAS Inhibitor–Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Secondary use and scholarly impact of a portfolio of clinical trials with shared individual participant level data: cross sectional study

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Professional Identity Formation in the Transition From Undergraduate to Postgraduate Medical Education: A Scoping Review

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Pharmacological Targets for Periodontitis: A Systematic Review of Drug‐Target Mendelian Randomisation Studies

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Response to “Efficacy and Safety of Tegoprazan‐Amoxicillin Dual Therapy for <scp> Helicobacter pylori </scp> Eradication: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Controlled Trials”

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Treatment escalation patterns, infection risk and clinical outcomes in refractory <scp>CCLE</scp> in <scp>SLE</scp>

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Perceptions of doctors disclosing AI use in their online biographies: evidence from an experiment

CrossrefOriginal source

🌍Sep 2Researchdoi.org

A phase-based analytic hierarchy process–decision–making trial and evaluation laboratory approach for prioritizing building information modelling–enabled digital transformation criteria in geotechnical projects: the case of Türkiye

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Phosphodiesterase-5 Inhibitor Use and Clinical Outcomes in Left Ventricular Assist Device Recipients: A Real-World Analysis of 31,465 Patients

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Iron deficiency during pregnancy and lactation

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Effects of Upper Extremity Strength Exercises in Subacromial Impingement Syndrome: A Systematic Review

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Development of adjuvanted HIV vaccines tailored for early life: immunologic rationale, clinical experience, and future directions

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease: 10-year outcome from the DANAMI-3–PRIMULTI trial

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Modeling uncertainty in performance validity testing with Bayesian logistic regression

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Lived experience in layers – personal, professional and partnership: an autoethnographic exploration of the evaluation of a drug education programme

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Discovery and preclinical validation of a translationally optimized mitochondrial complex I modulator for Alzheimer’s disease

CrossrefOriginal source

🌍Sep 2Researchdoi.org

An umbrella review of ethical challenges in clinical trials conducted in low and middle income countries

CrossrefOriginal source

🌍Sep 2Researchdoi.org

AI-driven drug discovery and personalized medicine: integrating quantum computing and next-generation technologies

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Prognostic Markers in CKD Patients Stratified by Co-morbid Conditions and on Dialysis Therapy

CrossrefOriginal source

🌍Sep 2Researchdoi.org

Socioeconomic Inequalities in Dietary Diversity and Nutritional Status Among Early School-age Children in Bankura District of West Bengal, India

CrossrefOriginal source

Pharmaceutical industry news

Vitamin D Supplementation in Infertile Men: Beyond Pooled Effects—A Critical Meta-Analysis of Heterogeneous Clinical Responses

Clinical application of sugammadex in renal impairment: pharmacokinetics and pharmacodynamics

Correction: Comparative assessment of the activity of racemic and dextrorotatory forms of thioctic (alpha-lipoic) acid in low back pain: preclinical results and clinical evidences from an open randomized trial

Repeated voriconazole therapeutic drug monitoring in hospitalised patients: a real-world cohort study of out-of-range exposure and concentration response to dose adjustment

Editorial: From black-box to clarity in lesion diagnostics: clinical causal cognition led interpretable diagnostic AI systems

Gut microbiota dysbiosis and the gut–lung axis in COPD: mechanisms, clinical relevance, and microbiota-targeted interventions

Review of: "Integrity of Clinical RCTs: Safeguarding Trust, Evidence, and Patient Welfare"

Recognizing strengths in individuals with ADHD: Exploring experiences and applications in clinical practice

The impact of intraoperative epiaortic scanning of the ascending aorta on the tactics and outcomes of coronary artery bypass grafting (literature review)

Identifying key prognostic indicators for extended hemodialysis survival: A comprehensive analysis of clinical, laboratory, and demographic factors

Evaluation of natural and synthetic photosensitizers in visible light-mediated antimicrobial photodynamic therapy against pathogenic bacteria

Cancer Outcomes in Low- and Middle-income Countries: The Role of Clinical, Sociodemographics, and Public Funding as Drivers

Prediction of non-surgical spinal decompression efficacy in lumbar disc herniation patients is based on pre-treatment paravertebral muscle MRI radiomics and clinical factors in a two-center study with external validation.

Optimizing Physiological Image Compression via Discrete Wavelet Transform without Loss of Clinical Relevance

Clinical and Inflammatory Benefits of Nebulized Furosemide with Salbutamol–ipratropium in COPD Exacerbations: A Randomized Controlled Trial

Study of the clinical presentation and antibiotic susceptibility pattern of Burkholderia pseudomallei infection from a tertiary care hospital

Approach to the Patient: Theranostics as precision medicine for neuroendocrine tumors

Association of admission LDL cholesterol with clinical profile and 3-months outcomes after ischaemic stroke

Knowledge, TDM-related practices, and training needs regarding the clinical use of vancomycin among healthcare professionals in China: a cross-sectional survey

Mistreatment, gender differences, and reporting behaviors among medical students in clinical training in Taiwan: a nationwide cross-sectional study

Clinical rationale and indications for the use of cone-beam computed tomography

Evaluating a sexual violence primary prevention program at an Australian University: a realist protocol comprising a cluster non-randomized controlled trial and realist interviews

Automated whole-brain MRI segmentation combined with clinical scores for the diagnosis of sepsis-associated encephalopathy: a case-control study

Wellbeing, mastery and work participation: Effects of the Five Ways to Wellbeing course—a randomized controlled trial

Intravascular hemolysis and clinical outcomes in continuous-flow LVAD patients: A single-center retrospective analysis

Data from Antibody–Drug Conjugates Prepared with Peptide Asparaginyl Ligases Achieve Strong &lt;i&gt;In Vitro&lt;/i&gt; and &lt;i&gt;In Vivo&lt;/i&gt; Antitumor Activity

Supplementary Figure S2 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy

Supplementary Figure S3 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy

Supplementary Figure S5 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy

Supplementary Figure S7 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy

Supplementary Figure 4 from Antibody–Drug Conjugates Prepared with Peptide Asparaginyl Ligases Achieve Strong &lt;i&gt;In Vitro&lt;/i&gt; and &lt;i&gt;In Vivo&lt;/i&gt; Antitumor Activity

Supplementary Figure 6 from Antibody–Drug Conjugates Prepared with Peptide Asparaginyl Ligases Achieve Strong &lt;i&gt;In Vitro&lt;/i&gt; and &lt;i&gt;In Vivo&lt;/i&gt; Antitumor Activity

Supplementary Figure 7 from Antibody–Drug Conjugates Prepared with Peptide Asparaginyl Ligases Achieve Strong &lt;i&gt;In Vitro&lt;/i&gt; and &lt;i&gt;In Vivo&lt;/i&gt; Antitumor Activity

Varying Cancer Drug Doses to Balance Tumor Control and Resistance Evolution

Supplementary Information from Evolutionary Antifragile Therapy Is a Treatment Strategy to Suppress Drug Resistance by Exploiting Dose–Response Convexity

Figure 2 from KRAS Inhibitor–Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones

Figure 5 from KRAS Inhibitor–Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones

Figure S11 from KRAS Inhibitor–Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones

Figure S4 from KRAS Inhibitor–Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones

Figure S5 from KRAS Inhibitor–Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones

Table S3 from KRAS Inhibitor–Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones

Secondary use and scholarly impact of a portfolio of clinical trials with shared individual participant level data: cross sectional study

Professional Identity Formation in the Transition From Undergraduate to Postgraduate Medical Education: A Scoping Review

Pharmacological Targets for Periodontitis: A Systematic Review of Drug‐Target Mendelian Randomisation Studies

Response to “Efficacy and Safety of Tegoprazan‐Amoxicillin Dual Therapy for <scp> <i>Helicobacter pylori</i> </scp> Eradication: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Controlled Trials”

Treatment escalation patterns, infection risk and clinical outcomes in refractory <scp>CCLE</scp> in <scp>SLE</scp>

Perceptions of doctors disclosing AI use in their online biographies: evidence from an experiment

A phase-based analytic hierarchy process–decision–making trial and evaluation laboratory approach for prioritizing building information modelling–enabled digital transformation criteria in geotechnical projects: the case of Türkiye

Phosphodiesterase-5 Inhibitor Use and Clinical Outcomes in Left Ventricular Assist Device Recipients: A Real-World Analysis of 31,465 Patients

Iron deficiency during pregnancy and lactation

Effects of Upper Extremity Strength Exercises in Subacromial Impingement Syndrome: A Systematic Review

Development of adjuvanted HIV vaccines tailored for early life: immunologic rationale, clinical experience, and future directions

Complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease: 10-year outcome from the DANAMI-3–PRIMULTI trial

Modeling uncertainty in performance validity testing with Bayesian logistic regression

Lived experience in layers – personal, professional and partnership: an autoethnographic exploration of the evaluation of a drug education programme

Discovery and preclinical validation of a translationally optimized mitochondrial complex I modulator for Alzheimer’s disease

An umbrella review of ethical challenges in clinical trials conducted in low and middle income countries

AI-driven drug discovery and personalized medicine: integrating quantum computing and next-generation technologies

Prognostic Markers in CKD Patients Stratified by Co-morbid Conditions and on Dialysis Therapy

Socioeconomic Inequalities in Dietary Diversity and Nutritional Status Among Early School-age Children in Bankura District of West Bengal, India

Data from Antibody–Drug Conjugates Prepared with Peptide Asparaginyl Ligases Achieve Strong <i>In Vitro</i> and <i>In Vivo</i> Antitumor Activity

Supplementary Figure 4 from Antibody–Drug Conjugates Prepared with Peptide Asparaginyl Ligases Achieve Strong <i>In Vitro</i> and <i>In Vivo</i> Antitumor Activity

Supplementary Figure 6 from Antibody–Drug Conjugates Prepared with Peptide Asparaginyl Ligases Achieve Strong <i>In Vitro</i> and <i>In Vivo</i> Antitumor Activity

Supplementary Figure 7 from Antibody–Drug Conjugates Prepared with Peptide Asparaginyl Ligases Achieve Strong <i>In Vitro</i> and <i>In Vivo</i> Antitumor Activity